Handbook on Epilepsy for Physicians PV Rai, HV Srinivas, P Satishchandra, GT Subhas
INDEX
Page numbers followed by b refer to box, f refer to figure, fc refer to flowchart, and t refer to table
A
Acetazolamide 52
Acidosis 49
Alcohol withdrawal 56
Alopecia, transient 102
Alpha amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 96
Alzheimer's dementia 32
Alzheimer's disease 43
American Academy of Pediatrics 23, 51
American Epilepsy Society 90
Anemia 102
aplastic 102
Anion gap acidosis 73
Anorexia 102
Anoxia, perinatal 27
Antashubba 1
Anterior temporal resection 131
Antibiotics 43
Antibody
antinuclear 38
autoimmune 31, 38
paraneoplastic 38
Antidepressants 43
specific serotonergic 61
Antidiscriminatory law 147
Antiepileptic drugs 5, 12, 22, 32, 48, 56, 60, 74, 78, 85, 99, 101t, 115, 122, 126t, 148, 151
adverse effects of 102t
choice of 99, 125t
induced cardiac malformations 49
pharmacodynamics of 41
pharmacokinetics of 41
role of 60
selection 44
teratogenic effects of 49
Antiepileptic medications 44, 88
Anti-gamma-aminobutyric acid 31
receptor antibodies 31
Anti-leucine-rich glioma-inactivated 31, 96
Anti-N-methyl-D-aspartate 31
Antipyretic drugs 13
Anti-thyroid peroxidase 37
Anxiety disorders 26, 58, 60
Apasmara 1
Arrhythmias, cardiac 41
Aspirin 14
Astrocytoma 36
Ataxia 92, 102
Atkins diet, modified 128
Atresia, pulmonary 49
Atrial septal defect 49
Attacks
severe recurrent 15
shuddering 17
transient ischemic 30, 41, 43
Attention-deficit hyperactivity disorder 26, 65
Autism-spectrum disorders 26
Autonomic function tests 30
Autosomal dominant 70
disorder 11
frontal lobe epilepsy 70
juvenile myoclonic epilepsy 70
nocturnal frontal lobe epilepsy 69
partial epilepsy with auditory features 70
B
Bangalore Urban and Rural
Neuroepidemiological Survey 42
Beck's depression inventory 141
Behavioral changes 102
Behavioral problems 111
Behavioral therapies 141
Benzodiazepines 105
gamma-aminobutyric acid 60
oral 88
parenteral 89
trial 95f
Biochemical tests 77
Bone marrow depression 102
Bradyarrhythmia 55
Brain 1, 73, 99
damage
risk of 15
structural 56
disorder of 30
human 4
injury, traumatic 36, 43, 144
neurotransmitters 45
presence of 8
tumor 36, 90
Breath-holding spell 10, 17, 18
Brivaracetam 105
Broad-spectrum parenteral anticonvulsants effective against multiple seizure types 89
Brudzinski signs 10
C
Calcification 83
Calcium 8
Carbamazepine 5, 33, 44, 49, 60, 72, 100103, 116, 125, 126
Cardiopulmonary resuscitative procedures 15
Carotid sinus syndrome 41
Catamenial epilepsy 52
Catastrophic seizure syndromes 28
Cavernous angiomas 32
Central nervous system 32, 34, 89
infection 10, 144
rule out 10
Centrotemporal spikes 80, 110
Cerebrovascular disease 144
Charaka Samhita 1
Chest
infections 42
X-ray of 43
Chills 10
Chromosomal microarray 75
Clinical psychologist, role of 141
Clobazam 33, 52, 92, 101, 102, 105, 125, 126
oral 88
Clonazepam 92, 102
Cognitive behavioral therapy 61, 141
Commissure
anterior 82
posterior 82
Commitment therapy 61
Comprehensive epilepsy care centers 129
Computed tomography 126, 127
scan 112
Computer 156
Confusion 92, 102
Consciousness 94f
assessment of 10
Continuous therapy 13
indications for 13
Contraception 51
Conventional antiepileptic drug therapy 23
Convulsions
neonatal 27
study of 2
Convulsive diseases, chronic 3
Corpus callosotomy 132
Cortical development, malformations of 24, 25
Corticotrophin-releasing hormone 153
Cough syncope 55
Craniofacial defects 49
Cysticercosis 89
D
De novo
mutation 11
psychosis after epilepsy surgery 63
Deep brain stimulation 133
Deep tendon reflex, assessment of 10
Dementias 43, 90
Deoxyribonucleic acid 71
Depression 58, 102
cardiac 92
respiratory 92
screening for 60
treatment strategies for 60
Depressive disorder 26
Diabetes 55
gestational 49
Diazepam 13, 90
oral 88
Diet 156
Diffusion-tensor imaging 83
Diffusion-weighted image 34
Diphtheria/tetanus/pertussis 8
Diplopia 102
Divalproate 60
Dizziness 102
Doose syndrome 68
Doshas 1
Down syndrome 90
Dravet syndrome 8, 10, 11, 26, 68, 72, 111
Drop attacks 18, 28
Drowsiness 92
Drug 56
compliance 124
resistant epilepsy 105, 122, 123, 129
management of 123
withdrawal
after seizure freedom 115
benefits of 116
risks of 117
Duloxetine 61
Dysautonomia, primary 55
Dysembryoplastic neuroepithelial tumors 24, 129
Dyskinesia, paroxysmal 30
Dyslipidemia 26
Dysplasia 24
focal cortical 32, 83, 131
E
Edema, perilesional 35f
Electrocardiogram 30, 43
Electroclinical syndromes 90
Electroconvulsive therapy 93
Electroencephalogram 3, 11, 18, 20, 22, 31, 42, 63, 107, 152
Electroencephalography 77, 85fc, 99, 112, 117, 123
abnormalities 80t
continuous 93
role of 93
Electrolytes, serum 43
Electrophysiological procedures 80
Electrophysiology 77
clinical 130
Elekta Neuromag® Triux Magnetoencephalography Machine 81f
Encephalitis 10, 55, 90, 111
autoimmune 32, 37, 96
viral 56
Encephalopathy 92
autoimmune 31
developmental 23
epileptic 16, 23, 69, 72
hepatic 56
metabolic 56
mitochondrial 70
renal 56
steroid-responsive 37
Enzyme
inducibility 45
induction 92
Ephedrine 32, 56
Epigenetics 71
Epilepsy 13, 6, 1619, 26, 30, 36, 42, 46, 48, 54, 56, 56t, 58, 61, 64, 65, 67, 77, 77t, 83, 85, 99, 104, 107, 109, 133, 137, 138, 143, 148, 151, 158
absence of 65, 80
adult-onset 16, 34
and cognition 153
and counseling 137
and disability 147
and driving 146
and employment 147
and epilepsy syndromes 16
and exercise 152
and functional anatomy 4
and income tax 147
and insurance 147
and law 146
and marriage 146
and psychiatric aspects 58
and yoga 151
anxiety disorders in 60
benign 26
childhood 16, 17, 21, 25, 26, 80
classification 28, 107
cryptogenic 125
development of 14
diagnosis of 41, 80, 107, 109, 112
education and employment 148
emergencies in 88
epidemiology of 41
etiology of 41
famous persons with 164
focal 109, 110
frontal lobe 18, 65
generalized 8, 25, 109, 110
genetic 67
basis of 67
causes of 69, 73
diagnosis of 67
history of 1
idiopathic 16, 31
generalized 68, 80, 110, 122, 125
in elderly 41
investigation of 77, 112
juvenile
absence 90, 110, 122
myoclonic 31, 32, 51, 64, 79, 80, 90, 110, 116, 122
management of 4, 52, 143
medical treatment of 73, 99
medically refractory 73, 105
mesial temporal 33, 83, 130
metabolic 111
mitochondrial 72
myoclonic 32, 70
neurological disorders depression inventory for 60, 141
new-onset 3032, 38
idiopathic generalized 100
partial 100
on pregnancy 48
pediatric 25, 27, 28, 134
pharmacokinetics of 73
pharmacoresistant 27
phenotypic characteristics of 16
post-traumatic 36
prevention of 143
primary
generalized 94f
new-onset 31
protocol magnetic resonance imaging 82t
pyridoxine-dependent 72
recent classification of 116
refractory 105, 105t, 122, 123
secondary new-onset 34
self-limited 110
occipital 110
severe myoclonic 8
short history of 1
stigma of 54
sudden unexplained death in 151
surgery for 129
symptomatic 16, 25, 125
focal 24
syndrome 18, 20, 20t, 21, 22, 67, 110, 110t
febrile infection-related 10, 11, 90
identification of 110
self-limiting focal 21t
specific 26
temporal lobe 59, 64, 68, 80
therapy resistance in 122
treatment of 6, 41
types of 80
with complex inheritance 69
Epileptic syndrome 11, 31, 42, 80t
Epileptiform discharges, absence of 112
Epileptogenic lesions 83t
Erythrocyte sedimentation rate 34
Escitalopram 61
Eslicarbazepine 101
Ethosuximide 102
European Association of Epilepsy Centers 5
European Forum on Epilepsy Research 6
Everolimus 72
Exercise, role of 151
Extratemporal resection 131
Ezogabine 72
F
Falling disease 1
Fallot's tetralogy 49
Father of medicine 1
Fatigue 92, 102
paresthesias 102
Febrile
delirium 10
episode 13
myoclonus 10
seizures 79, 14, 15, 23, 56
development of 8
first 12
majority of 11
plus 68, 70
syndrome 8, 25
treatment of 11
Felbamate 101, 102
Fenfluramine 72
Fetal
heart rate 49
hypoxia 49
Fever 10
causes of 10
infections 8
low-grade 12
Fluid attenuated inversion recovery 34, 82
Fluoxetine 61
Folic acid 8
Fosphenytoin 12, 92
Functional magnetic resonance imaging 84f
G
Gabapentin 43, 100, 104
Gait problems 111
Galen's theory 2
Gamma-aminobutyric acid 8, 96
Ganglioglioma 24, 83
Gastroenteritis 8
Gastrointestinal
irritation 102
malformations 49
Gator1 complex 72
Genetic 8
epilepsy 16, 31, 70, 71, 74fc, 118
syndromes 70t
etiology 19
factors 8
generalized epilepsy 110
testing 11
Genomic imprinting, disorder of 73
Ginkgo biloba 43
Glaucoma 102
Gliosis 111
Global Campaign Against Epilepsy 5
Glucose
transporter deficiency 71, 72
syndrome 27
Glucuronidation, hepatic 51
Glutamic acid decarboxylase 96
Granulomas 34
cysticercal 32
neurocysticercal 34t
tuberculous 34t
Growth hormone deficiency 26
Gum hyperplasia 102
H
Hamartoma, hypothalamic 19, 25
Hans Berger 3
Hashimoto's encephalopathy 37
Head
injury 56
trauma 36
Headache 102
Hearing 73
loss, sensorineural 69
Heart 73
disease, structural 41
Hemiconvulsion-hemiplegia epilepsy 19
Hemiparesis, transient 9
Hemispherectomy 131
Hemispherotomy 131
Hemogram 43
Hemorrhage 49
postpartum 49
Henri Jean Pascal Gastaut 4
Hepatic failure 102
Hepatotoxicity 13, 93, 102
Herpes
encephalitis 32
simplex 55
Hippocrates 2
Hirsutism 102
Histone modifications 71
Holter monitoring 30
Hospital Anxiety and Depression Scale 141
Human immunodeficiency virus 32, 36
Hydronephrosis 49
Hyperammonemia 13, 73, 92, 102
Hyperekplexia 17
Hyperglycemia 32, 41, 42
Hypernatremia 32, 41
Hyperphagia 64, 65
Hypersexuality 64
Hypertensive disorders 49
Hyperthermia 64
Hypnic jerks 41
Hypocalcemia 30, 32, 34, 41, 42, 44, 54, 56, 73
Hypohidrosis 102
Hypometabolism, severe 84f
Hyponatremia 32, 34, 41, 42, 56, 102
Hypospadias 49
Hypotension 92
orthostatic 41
Hypothermia, therapeutic 93
Hypothyroidism 26, 42
Hypoxia, maternal 49
Hypsarrhythmia 80
I
Immunization 8
Immunoglobulin 37
Indian Academy of Neurology 160
Indian Epilepsy Association 6, 146, 158160
activities of 160
birth of 159
Infantile spasm 18, 26, 69
Infections 34, 111
extracranial 8
Infertility 48
Insomnia 102
Intensive care unit 96
Interictal epileptiform discharges 78
Intermittent therapy 13
indications for 13
International 1020 Montage System 79f
International Bureau for Epilepsy 158
International Classification of Epileptic Seizures and Epilepsies 5
International Epilepsy Day 161
International League Against Epilepsy 4, 18, 67, 116, 158
Classification of Seizure Types Basic Version 108f
Classification of Seizures and Epilepsies 107
Framework for Classification of Epilepsies 108f
International Neuropsychiatric Interview Plus 60
Intoxication 90
Intracranial infection, acute 7
Intrauterine
device 51
growth retardation 9
Iron 8
J
Japanese encephalitis 55
Jitteriness 17
John Hughlings Jackson 2
K
Kapha 1
Kernig's signs 10
Ketamine 93
Ketogenic diet 72, 93, 128
Kidney 73
Klüver-Bucy syndrome 64
L
Lacosamide 12, 33, 92, 105, 125, 126
Lactic acidosis 70
Lafora's disease 69, 85, 90
Lamotrigine 33, 43, 48, 72, 100102, 125, 126
Landau-Kleffner syndrome 26
Language impairment 26
Laser intermittent thermal ablation treatment 133
Learning disability 111
Lennox-Gastaut syndrome 3, 4, 26, 69, 80, 90, 104
Lesionectomy 131
Lethargy 102
Leukopenia 102
Levetiracetam 12, 33, 43, 92, 100102, 125, 126
Levodopa 43
Limbic encephalitis 23
Liver 73
enzymes, elevated 92
failure 42, 105
function tests 43
Lorazepam 90, 95f
Lumbar puncture 11, 96
Lymphadenopathy 102
M
Magnetic resonance imaging 11, 77, 81, 83t, 84f, 85f, 99, 112, 127, 130
Magnetoencephalography 126, 127, 130
Malaria 90
Malformations
arteriovenous 32
major congenital 49
Manganese 8
Marriage, low rates of 48
Masturbation 17, 64
Mean spectral intensity 152
Memantine 72
Memory disorders 65
Mendelian inheritance 69
Meningeal irritation, signs of 10
Meningioma 36
Meningitis 10
bacterial 56
cryptococcal 36
Menstrual irregularities 48
Mental
disorders, statistical manual of 59
retardation 27
stress 48
Metabolism
hepatic 45
inborn error of 73
several inborn errors of 23
Metastatic lesions 36
Methylation 71
Micturition syncope 55
Midazolam 88, 91, 93
Midline craniofacial anomalies 49
Migraine 17, 18
complicated 30
Miscarriages 49
Mitochondrial
disease 69
inheritance 69, 70
syndromes 85
Mood
disorders 26
symptoms 64
Morbus Divus 2
Morbus Sacer 2
Motor disabilities 111
Motor vehicle Act 146
Movement disorders 30, 111
Multifocal paraneoplastic disorders 23
Multiorgan involvement 34, 73
Multiple subpial transections 28, 132
Muscle 73
biopsy 77
oligodendrocyte glycoprotein 37
tone and power, assessment of 10
Myoclonic disease, severe 69
Myoclonus 92
Myopathy sensory ataxia 70
N
Narcolepsy 41
National Epilepsy Day 161
National Institute of Mental Health and Neurosciences 152
Neonatal epilepsy, benign familial 69, 70
Neonatal intensive care unit 9
Nerve 73
Nervous system malformations 49
Neural tube defects 49
Neurocysticercosis 34, 35f
Neuroleptics 43
Neurological disorder, chronic 58
Neurological Society of India 6
Neuromyelitis optica 37
Neuronal ceroid lipofuscinosis 85
adult-onset 32
Neurons, epileptic 4
Neuropsychiatric disorder, developmental 25
Neurostimulation 133
responsive 133
Neurosyphilis 32, 36
Neurotuberculosis 34
Nimesulide 14
N-methyl-D-aspartate 23, 96
Nonepileptic attack 30
disorder 54, 56, 56t
Nonmendelian inheritance 69
Norepinephrine-dopamine reuptake inhibitors 61
O
Obsessive compulsive disorder 65
Ocular hypertelorism 49
Oligodendroglioma 36
Orbitofrontal lesions 65
Osteomalacia 102
Otitis media 8
Oxcarbamazepine 125, 126
Oxcarbazepine 33, 100102
P
Panayiotopoulos syndrome 21, 90
Pancreatitis 92
Panic attacks 55
Papilledema 10
Paracetamol oral 13, 15
Parenchymal hemorrhagic lesions 36
Paresthesias 92
Parkinson's disease 55
Paroxysmal torticollis, benign 17
Paroxysmal vertigo, benign 17
Patent ductus arteriosus 49
Pediatric neurologic disorders 16
Pentobarbital 93
Perampanel 105
Persons with epilepsy 1, 58, 115, 129, 145, 146, 148, 152, 156, 158
Phenobarbital 50, 101, 105
Phenobarbitone 12, 13, 92, 100, 102, 116, 125, 126
Phenylephrine 32, 56
Phenytoin 5, 44, 50, 92, 94f, 100103, 116, 125, 126
intravenous 12
Phosphorus metabolism 41
Pitta 1
Pleitropy 67
Pneumonia 8
Polycystic ovary syndrome 26
Polymicrogyria 24
Polypharmacy 45
Porphyria 105
Positron emission tomography 5, 77, 83, 84f, 126, 127
Premature birth 8
Presyncope 30
Prevention Task Force of International League Against Epilepsy 143
Primidone 49, 104
Propofol 93
Protein binding 45
Pseudocrisis 18
Pseudoseizures 124
Psychiatric
comorbidities 26
conditions 111
Psychic blindness 64
Psychogenic crises 17
Psychosis 26, 6163, 102
chronic interictal 63
in persons with epilepsy 61
interictal 65
postictal 62
prevalence of 61
Public Awareness Programs 161
Pyridoxine 27, 72, 93
Q
Quinidine 72
Quinolones 32, 56
R
Radiofrequency thermocoagulation 133
Radiosurgery 132
Randomized controlled trials 46
Rapamycin inhibitors, mammalian target of 72
Rapid eye movement 41
Rasmussen syndrome 19
Rectal preparation 12, 14
Regression, developmental 73
Renal agenesis 49
Renal failure 104
Renal function tests 43
Renal stones 102
Respiratory rate, monitor for 91
Restless legs syndrome 41
Retigabine 101
Ribonucleic acids 71
noncoding 71
Rolandic epilepsy 80
Rolandic seizure 18
S
Sandifer syndrome 17, 18
Sclerosis
hippocampal 19, 82, 111
mesial temporal 24, 3133, 95f, 129, 131
multiple 37
tuberous 72
Sedation 102
Seizures 3, 811, 17, 19, 48, 54, 55, 55t, 69, 88, 107, 138
absence 11, 18
acute 44
repetitive 88
and epilepsy, first unprovoked 43
atonic 11
characteristics 10
cluster 88
complex
febrile 9, 9t, 59
partial 79f
convulsive 163
differential diagnoses of 41b
disorders 145
drug induced 34
duration of 10
during pregnancy, recurrence of 48
early-onset 36
epileptic 30, 115, 117
focal 18, 19, 31
frequency 52
generalized 16, 19, 109
hysterical 54
isolated 34, 88
migrating partial 72
myoclonic 11, 18
neonatal 73
nonepileptic psychogenic 41
occipital lobe 18
paradoxical worsening of 92
poststroke 34, 36
post-traumatic 34, 36
prolonged febrile 11
provoked 42, 56b
psychogenic 54
nonepileptic 124
reduction 28
re-emergence of 49
sensory 41
simple febrile 9, 9t
temporal lobe 18
types 18, 2022
classification of 19b
identification of 107
typical febrile 68
Selective serotonin-norepinephrine reuptake inhibitors 61
Selenium 8
Sertraline 61
Sexual maturation-related issues 26
Single-photon emission computed tomography 77, 83, 126
Skin 77
rash 102
Sleep
apnea 41
benign epileptiform transients of 112
deprivation of 145
positive occipital sharp transients of 112
myoclonus, venign 17, 18
disorders 17, 18, 30, 41, 111
Sodium
channel blocker 72
valproate 5, 32, 49, 116, 125, 126
Somnolence 92
Spasm, march of 2
Spasmus nutans 17
Status epilepticus 10, 16, 18, 27, 41, 45, 8890
afebrile 12
classification of 89
convulsive 88, 91fc
De novo 90
epidemiology of 89
etiology of 90b
evaluation of 97fc
febrile 9, 10, 14
first-line antiepileptic drugs in 92t
management of 90
medical management of 90
new onset refractory 90
nonconvulsive 18, 88, 91fc, 96
refractory 93
second-line antiepileptic drugs in 92t
Stereotactic techniques 132
Steroids, high-dose 37
Stevens-Johnson syndrome 102
Stiripentol 72
Stokes-Adams syndrome 55
Stroke 56, 89, 90, 111
like episodes 70
Supportive therapy 141
Surgically remediable syndromes 129
Syncope 17, 18, 30, 43, 54, 55, 55t
common types of 55b
convulsive 30
Systemic lupus erythematosus 32
T
Tachyarrhythmia 55
Taenia solium 34, 144
Teratogenesis, cognitive 50
Testis, undescended 49
Tetracyclic antidepressants, use of 61
Theophylline 43
Thiazides 43
Thrombocytopenia 92, 102
transient 92
Thyroiditis, autoimmune 37
Thyrotoxicosis 41
Tiagabine 101
Tics 17
Todd's paresis 9
Tonic spasms 18
Tonic upward gaze, benign paroxysmal 17
Tonic-clonic seizure 18
generalized 11, 18, 31, 44, 49, 110, 116
Topiramate 33, 51, 92, 100102, 104, 125, 126
TORCH infections, congenital 111
Toxoplasmosis 36
Tramadol 32
Transcranial magnetic stimulation 93
Trauma 111
Tremor 102
Tricyclic antidepressants, use of 61
Tuberculoma, right parietal 35f
Tuberculosis 32, 34
granuloma 34
Tumors 32, 36, 111
low-grade 36
Typhoid 54
U
Unverricht-Lundborg disease 69, 70
Upper respiratory infection 8
Uremia 42
Urinary ketones 73
Urinary tract infection 8, 42
V
Vagal nerve stimulation 28, 127, 133
Valproate 12, 13, 33, 92, 100, 101, 105
Valproic acid 43, 44, 102
Vasculitis 32
Vasovagal syncope 30, 41
Venereal Disease Research Laboratory 38
Venlafaxine 61
Ventricular septal defect 49
Vertigo 92, 102
Video electroencephalography 85, 127
Vigabatrin 101, 104
Viral infections 8
Visual agnosia 64
Vitamin
B12 8
D supplements 44
W
Weight
gain 102
loss 102
West's syndrome 80, 104
Wilder Graves Penfield 4
William Gordon Lennox 3
William Richard Gowers 3
Women with epilepsy 48
Women, epilepsy and pregnancy 48
World Health Organization 5
X
X-linked disorders 70
Y
Yoga, role of 151
Z
Zinc 8
Zonisamide 3, 102, 105, 125, 126
×
Chapter Notes

Save Clear


Short History of Epilepsy1

Rai PV,
Sreeram AC
 
INTRODUCTION
The history of epilepsy can be traced to early civilizations. The oldest mention is found in the Babylonian clay tablet, written in Sumerian language, during the reign of the Babylonian King Adad-apla-iddina (1067–1046 BC). The tablet, which is kept in the British Museum, is called “antashubba” meaning “falling disease” in Sumerian. This forms a part of such tablets on human diseases. Mention of epilepsy is found in the Bible, where Jesus Christ heals a boy with epilepsy. People then believed that epilepsy was caused by supernatural powers such as by Gods and evil spirits and the treatment consisted of driving away such spirits.
Ayurveda refers to epilepsy in the Charaka Samhita (1000–500 BC) as “Apasmara” and mentions several kinds of seizures, which are comparable to the present day clinical description. The cause of epilepsy is traced to the vitiation of three basic factors “Vata, Pitta, and Kapha” and the treatment consists in correction of these “Doshas”. Hippocrates of Kos (460–370 BC) referred to as the “Father of Medicine” made major contributions for understanding of epilepsy. At his time, epilepsy was considered a “sacred disease” probably because famous people like Alexander the Great and Julius Caesar had this disease in spite of their great military and leadership qualities. Hippocrates, in his treatise on “Sacred Disease”, declared epilepsy as a natural disease and traced its origin to the brain. He mentioned “it is thus with regard to the disease called sacred. It appears to me to be nowise more divine nor more sacred than other diseases, but has a natural cause from the originates like other affections. Men regard its nature and cause as divine from ignorance and wonder because it is not at all like other diseases. And, this notion of its divinity is kept up by their inability to comprehend it”.1
Hippocrates examined the skulls of people with epilepsy (PWE), which had holes in them probably to drive away the evil spirits. After examining the brains of such people, he came to the conclusion that the brain must be the organ responsible for seizures. However, Hippocrates believed that the disturbance of bodily (and brain) humors was responsible for causing2 seizures and the treatment he suggested was correction of this humoral imbalance.
zoom view
Hippocrates
Several centuries after Hippocrates, the Greek Physician Claudius Galen (130–210 AD), who founded his school in Rome, accepted the Hippocratic concept of brain as the seat of epilepsy. Galen's theory on pathophysiology of diseases including epilepsy rested on the basis of bodily humors and the treatment consisted of their correction with diet, bloodletting, and other procedures. Galen classified epilepsy as “idiopathic” meaning caused by brain humors and “sympathetic” referring to other irritating factors. Both the schools of Hippocrates and Galen considered epilepsy as a major disease and called it “morbus sacer” and “morbus divus”. The influence of these schools of ancient Greek medicine lasted for several generations but lost their significance over the succeeding centuries probably because of the lack of treatment against epileptic seizures. For centuries, PWE were at the mercy of faith healers and sorcerers of various kinds. Probably because of this situation, there is practically no mention on epilepsy in the history of medicine for the next 1,500 years.2
The modern history of epilepsy can be traced to the early 19th century in West European countries, which more or less coincided with the Industrial Revolution and then spread rapidly to North America and other countries. A French Physician, Dominique Esquirol (1772–1840), classified epilepsy into “grand mal and petit mal” and differentiated epilepsy from psychiatric conditions. Two British neurologists, William Richard Gowers (1845–1915) and John Hughlings Jackson (1835–1911), made significant contributions toward understanding epilepsy as a functional disorder of the cerebral cortex. Around the first part of 19th century, neurology evolved itself into a separate medical discipline, away from psychiatry and internal medicine, depending upon the situation of the medical practice.
The clinical and scientific work of John Hughlings Jackson paved the way for the understanding of seizures as excessive neuronal discharge of brain hemisphere corresponding to the contralateral extremities, also in the form of “March of spasm”. His work on the “Study of Convulsions” was a pathbreaker in the direction of “Epileptology” becoming a subspecialty of neurology.
zoom view
John Hughlings Jackson
Jackson devoted a major part of his professional career of over 40 years for the study of epilepsy, which formed the basis for further studies by his contemporaries and neurologists3 of succeeding generations of 19th and 20th centuries. His definition that “epilepsy is the name for occasional, sudden, excessive, rapid, and local discharges of gray matter” holds good, particularly for focal epilepsies even today.3 The beginning of the 20th century noticed further publications related to epilepsy from several distinguished neurologists.
William Richard Gowers published in 1881 a monograph “epilepsy and other chronic convulsive diseases”. In 1907, he published his second book “The Borderland of Epilepsy” in which he referred to the differential diagnosis of other seizure-like conditions such as vertigo, vasovagal attacks, migraine, and narcolepsy. Gowers was known for his clinical accuracy and pathophysiology of epilepsy. His concept of “seizures beget seizures” has some clinical significance even today.
In 1924, Hans Berger (1873–1941), a German psychiatrist from the University of Jena, succeeded in recording the first human electroencephalogram (EEG), with which he had hoped to detect “the correlation between objective activity of the brain and subjective psychic phenomenon”. After initial disappointment, he published his paper “recording the electrical activity of the human brain from the surface of the head” in 1929.2
The medical profession, to begin with, was somewhat skeptical of Berger's invention, but after it was certified by American and British neurophysiologists, EEG was technically improved and fully accepted as the method of investigation in the diagnosis/differential diagnosis of epilepsy, which continues even today, however, in a much sophisticated form.
William Gordon Lennox (1884–1960) was an American neurologist and a leading personality in the further development of Epileptology. He is widely known because of his intensive clinical and EEG work on childhood encephalopathy known as “Lennox-Gastaut syndrome” described later by another pioneer Henri Gastaut. Lennox developed interest for epilepsy during his service as a missionary Doctor in China and after returning to USA, he intensified his work on the severe form of childhood epilepsy syndrome making widespread EEG studies along with his colleagues Stanley Cobb, Erna, and Frederic Gibbs.
zoom view
William Richard Gowers
zoom view
Hans Berger
zoom view
William Gordon Lennox
4
His book “Epilepsy and Related Disorders”, co-authored with his daughter Margaret Buchtal, is popular even today. Lennox took active interest in the medicosocial aspects of epilepsy. He was president of the International League against Epilepsy (ILAE) from 1935 to 1946 and editor of the Journal Epilepsia from 1945 to 1950.3
zoom view
Wilder Graves Penfield
Wilder Graves Penfield (1891–1976) was a famous Canadian neurosurgeon with multi-sided interest involving medicine, philosophy, and literature. In Epileptology, he is known for his pathbreaking work for surgically removing “epileptic neurons” where the seizures originate. Penfield operated patients on local anesthesia and before the operation he electrically stimulated the brain to observe the focus of origin of seizures in conscious patients. Along with Herbert Jasper, he published his leading book “Epilepsy and the Functional Anatomy of the Human Brain”. Penfield's work has provided considerable service for the succeeding generation of neurosurgeons, neurologists, and epileptologists. Penfield has published several books on neuroanatomy, neurosurgery, epilepsy, psychology, and philosophy.4
zoom view
Henri Jean Pascal Gastaut
Henri Jean Pascal Gastaut (1915–1995) was a French neurologist who devoted his professional career in the service of Epileptology. He is widely known for the presentation of the Lennox–Gastaut syndrome, which he wished to publish in the name of William Lennox only, but the ILAE considering the efforts of Gastaut named the syndrome Lennox-Gastaut syndrome, under the initiative of Lennox's daughter Margaret Buchtal. Gastaut was actively involved in the activities of ILAE. He was the secretary general (1957–1969) and president (1969–1973) of ILAE. Gastaut is also known for the early classification of epileptic seizures and epilepsies by the ILAE, which has helped considerably in the clinical and EEG diagnosis/differential diagnosis of epilepsy.
 
FURTHER PROGRESS IN EPILEPSY MANAGEMENT
A milestone in the history of epilepsy is the introduction of bromide, the first ever effective antiepileptic drug by Charles Locock in 1857. Although a sedative, it was widely used for around half a century in European countries and North America. In the mid-19th century, several homes and colonies5 for PWE were founded in West European countries mostly by the Christian missionaries. Examples of such centers are Bethel, Bielefeld in Germany, Heemstede in Netherlands, Chalfont Center in England, Swiss Epilepsy Center, Zurich, Switzerland, Epilepsy Center Dianalund in Denmark, and Epilepsy Center in Sandvika Norway. These centers over the next 100 years have developed into full-fledged epilepsy (neuro) centers, taking care of the medical and social needs of PWE.5
Another important development was the foundation of the ILAE as early as in 1909, with the initiative of eminent neurologists like John Hughlings Jackson. The goal of ILAE is to promote worldwide research in the field of epilepsy for improving the lives of PWE. ILAE gives frequent guidelines for medical professionals like offering International Classification of epileptic seizures and epilepsies. It also runs the medical journal “Epilepsia”, which updates on epilepsy research and management. Much later in 1961, a second important organization, the International Bureau for Epilepsy (IBE), was founded by the initiatives of people like George Burden for the purpose of coordinating the social needs of PWE—on a worldwide basis. IBE has in its membership both medical professionals and the general public. IBE and ILAE work along with the World Health Organization (WHO) for a “Global Campaign against Epilepsy”.
Epileptology took strong roots in Europe and North America after World War II and spread rapidly to other countries. In 1912, a second important drug, phenobarbitone, was introduced, which considerably improved the prospects of antiepileptic therapy. Around the late 1960s, there were three more effective antiepileptic drugs—(1) phenytoin, (2) carbamazepine, and (3) sodium valproate. With these four drugs, about 70% of the PWE can be made seizure free. With the availability of more drugs, the quality of life can be improved with reduction of side effects and better seizure control. Medical technology made rapid advances with long-term videos—EEG, CT, MRI, and positron emission tomography (PET), which help in better diagnosis. Along with drug treatment, neurosurgery is helping PWE for further improvement of life. From an “incurable” condition of earlier centuries, epilepsy today is an eminently treatable neurological disorder, which, however, still carries a totally unjustifiable social prejudice.
During the recent history on epilepsy, much work is being done worldwide through the initiative of the two premier organizations, ILAE and IBE both in view of medical research and social aspects. The European Association of Epilepsy Centers (EAECs) started functioning in 1988 in Zurich and spread to other parts of Europe under the initiative of people like Christoph Pachlatko (1956–2015), Harry Meinardi (1932–2013), and others.
The purpose of this association is to emphasize the unique structure and function of these centers differentiating them from the usual neurological and neuropediatric hospitals/departments in way of offering comprehensive care to the PWE.66
The European Forum on Epilepsy Research (ERF 2013), which started in Dublin, under the auspicious of ILAE and IBE, has identified the following projects on epilepsy research: (1) epilepsy in the developing brain, (2) novel targets for innovative diagnostics and treatment of epilepsy, (3) what is required for prevention and cure of epilepsy? and (4) epilepsy and comorbidities with focus on aging and mental health, with the motive to: (i) strengthen epilepsy research, (ii) reduce treatment gap, and (iii) reduce the burden and stigma associated with epilepsy.7
 
INDIAN SCENARIO
zoom view
KS Mani
In the late 1960s, some senior Indian neurologists planned to start the Indian Epilepsy Association (IEA) independent of the Neurological Society of India (NSI) in order to accommodate nonmedical professionals for taking care of PWE. There was already an Epilepsy Section within the NSI, with Dr D Desai as secretary for the year 1968–1969. He along with Dr Eddie P Bharucha, Dr KS Mani, Dr Noshir H Wadia, and others, formed the IEA, independent of the NSI, which was registered on 21th March, 1970 in Bombay (now Mumbai).
The IEA was affiliated to IBE in December 1974. Since then IEA chapters have grown all over India. The Bangalore chapter increased its membership rapidly with regular monthly meetings. Thanks to the dynamic leadership of KS Mani (1928–2001), whose inspiration leads the Bangalore chapter even today.
REFERENCES
  1. Gabrielli F, Cocchi M, Levi D, et al. Historical-anthropological insights on epilepsy from Hippocrates to positivism. N Med. 2013;1:31–4.
  1. Rai PV. Step by Step Treatment of Epilepsy. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd;  2007.
  1. Magiorkinis E, Diamantis A, Sidiropoulou K, et al. Highlights in the history of epilepsy: the last 200 years. Epilepsy Res Treat. 2014;2014:582039.
  1. Jasper H, Penfield W. Epilepsy and the Functional Anatomy of the Human Brain, 2nd edition. United States: Little, Brown and Company;  1954.
  1. Vishwanath RP, Christian S. Special Epilepsy Centers in Western Countries and Epilepsy Services in Developing Countries. Zurich: University of Zurich Publication;  1990.
  1. Steinhoff BJ, Chatrou M, Hjalgrim H. Introduction: The European Association of Epilepsy Centers (EAEC). Epilepsy Behavior. 2017;76:S3.
  1. Baulac M, de Boer H, Elger C, et al. Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force. Epilepsia. 2015;56:1687–95.